Cargando…
Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy
Strontium ranelate (SR) is a pharmaceutical agent used for the prevention and treatment of osteoporosis and fragility fracture. However, little attention has been paid to the effect of SR on alveolar bone remodeling during orthodontic tooth movement and its underlying mechanism. Here, we investigate...
Autores principales: | Wu, Dongle, Sun, Xuan, Zhao, Yiwei, Liu, Yuanbo, Gan, Ziqi, Zhang, Zhen, Chen, Xin, Cao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045081/ https://www.ncbi.nlm.nih.gov/pubmed/36978756 http://dx.doi.org/10.3390/bioengineering10030365 |
Ejemplares similares
-
Polymeric strontium ranelate nonahydrate
por: Stahl, Kenny, et al.
Publicado: (2011) -
Cardiac concerns associated with strontium ranelate
por: Reginster, Jean-Yves
Publicado: (2014) -
Strontium Ranelate Ameliorates Intervertebral Disc Degeneration via Regulating TGF-β1/NF-κB Axis
por: Sun, Ruping, et al.
Publicado: (2023) -
Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
por: Geng, Tianxiang, et al.
Publicado: (2018) -
Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/-catenin pathway
por: Yu, Hao, et al.
Publicado: (2021)